Shenzhen TargetRx
Latest round
- Series A
Last raised
- Apr 2020
Total raised
- $21M
Investors
- 5
About Shenzhen TargetRx
Established in 2014 based in Shenzhen, China, Shenzhen TargetRx, Inc. operates as an anti-cancer drug developer focusing on research, development, sales, and service of targeted drugs for cancer therapy. The company has more than 200 inventions patented in China, the USA, Europe, and Japan. The company's Founder, Chairman, and CEO, Yihan Wang, graduated from the Department of Chemistry of New York University. He is one of the co-founders of the Chinese American Biomedical Association (CABA). The company has partnerships with CCB International, Shenzhen Capital Group, Shenzhen Acacia Investment, and Shenzhen Leaguer Tsing-Yuan Venture Capital Management. The company's products can be categorized into the next-generation Bcr-Abl allosteric inhibitor TGRX-678 and the third-generation ALK inhibitor TGRX-326, which have both conducted the dosing of the first subject in Phase I studies. The TGRX-326 is used to treat non-small cell lung cancer (NSCLC). The TGRX-678 is used to treat chronic myelogenous leukemia (CML). Shenzhen TargetRx, Inc. generates revenue by providing small - molecule targeted anti-cancer drugs to the pharmaceutical market and related R & D services to partners.
Who invested in Shenzhen TargetRx
5 investors across 2 rounds
See all investors in Shenzhen TargetRx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shenzhen TargetRx
Who invested in Shenzhen TargetRx?
Shenzhen TargetRx has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shenzhen TargetRx raised?
Shenzhen TargetRx has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Shenzhen TargetRx last raise money?
Shenzhen TargetRx's most recent round on record is a Series A, in Apr 2020.
What does Shenzhen TargetRx do?
Established in 2014 based in Shenzhen, China, Shenzhen TargetRx, Inc.
Where is Shenzhen TargetRx headquartered?
Shenzhen TargetRx is headquartered in Shenzhen, China.
Which VCs invest in companies like Shenzhen TargetRx?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Shenzhen TargetRx's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Shenzhen TargetRx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.